Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease

被引:11
|
作者
Mapel, Douglas W. [1 ]
Roberts, Melissa H. [1 ]
Sama, Susan [2 ]
Bobbili, Priyanka J. [3 ]
Cheng, Wendy Y. [3 ]
Duh, Mei Sheng [3 ]
Nguyen, Catherine [3 ]
Thompson-Leduc, Philippe [3 ]
Van Dyke, Melissa K. [4 ]
Rothnie, Kieran J. [4 ]
Sundaresan, Devi [2 ]
Certa, Julia M. [5 ]
Whiting, Thomas S. [5 ]
Brown, Jennifer L. [5 ]
Roblin, Douglas W. [5 ]
机构
[1] Univ New Mexico, Coll Pharm, 2502 Marble Ave, Albuquerque, NM 87106 USA
[2] Reliant Med Grp Inc, Worcester, MA USA
[3] Anal Grp Inc, Boston, MA USA
[4] GlaxoSmithKline Plc, London, England
[5] Midatlantic Permanente Res Inst MAPRI, Kaiser Permanente Midatlantic States KPMAS, Rockville, MD USA
关键词
claims database; algorithm; validation; electronic medical records; predictive values; AECOPD events; QUALITY-OF-LIFE; UNITED-STATES; COPD; COSTS; DIAGNOSIS; OUTCOMES; BURDEN;
D O I
10.2147/COPD.S302241
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important events that may precipitate other adverse outcomes. Accurate AECOPD event identification in electronic administrative data is essential for improving population health surveillance and practice management. Objective: Develop codified algorithms to identify moderate and severe AECOPD in two US healthcare systems using administrative data and electronic medical records, and validate their performance by calculating positive predictive value (PPV) and negative predictive value (NPV). Methods: Data from two large regional integrated health systems were used. Eligible patients were identified using International Classification of Diseases (Ninth Edition) COPD diagnosis codes. Two algorithms were developed: one to identify potential moderate AECOPD by selecting outpatient/emergency visits associated with AECOPD-related codes and antibiotic/systemic steroid prescriptions; the other to identify potential severe AECOPD by selecting inpatient visits associated with corresponding codes. Algorithms were validated via patient chart review, adjudicated by a pulmonologist. To estimate PPV, 300 potential moderate AECOPD and 250 potential severe AECOPD events underwent review. To estimate NPV, 200 patients without any AECOPD identified by the algorithms (100 patients each without moderate or severe AECOPD) during the two years following the index date underwent review to identify AECOPD missed by the algorithm (false negatives). Results: The PPVs (95% confidence interval [CI]) for both moderate and severe AECOPD were high: 293/298 (98.3% [96.1-99.5]) and 216/225 (96.0% [92.5-98.2]), respectively. NPV was lower for moderate AECOPD (75.0% [65.3-83.1]) than for severe AECOPD (95.0% [88.7-98.4]). Results were consistent across both healthcare systems. Conclusion: This study developed healthcare utilization-based algorithms to identify moderate and severe AECOPD in two separate healthcare systems. PPV for both algorithms was high; NPV was lower for the moderate algorithm. Replication and consistency of results across two healthcare systems support the external validity of these findings.
引用
收藏
页码:1687 / 1698
页数:12
相关论文
共 50 条
  • [31] Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Antibiotics Needed?
    Luppi, Fabrizio
    Beghe, Bianca
    Richeldi, Luca
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) : 102 - 103
  • [32] Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease
    Gulcev, Makedonka
    Reilly, Cavan
    Griffin, Timothy J.
    Broeckling, Corey D.
    Sandri, Brian J.
    Witthuhn, Bruce A.
    Hodgson, Shane W.
    Woodruff, Prescott G.
    Wendt, Chris H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2435 - 2446
  • [33] Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
    Jeppesen, Elisabeth
    Brurberg, Kjetil G.
    Vist, Gunn E.
    Wedzicha, Jadwiga A.
    Wright, John J.
    Greenstone, Michael
    Walters, Julia A. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05):
  • [34] Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Sethi, S
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S177 - S185
  • [35] Acute Kidney Injury In Exacerbations Of Chronic Obstructive Pulmonary Disease
    Barakat, M. F.
    Collier, T.
    Nitsch, D.
    Quint, J. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease
    Ni, Han
    Aye, Swe Zin
    Naing, Cho
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [37] Physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease
    Holland, Anne E.
    JOURNAL OF PHYSIOTHERAPY, 2014, 60 (04) : 181 - 188
  • [38] Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Woods, J. Andrew
    Wheeler, James S.
    Finch, Christopher K.
    Pinner, Nathan A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 421 - 430
  • [39] Effectiveness of antibiotics in acute exacerbations of chronic obstructive pulmonary disease
    Rothberg, M.
    Brody, O.
    Penelope, P.
    Lahti, M.
    Lindenauer, P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 296 - 296
  • [40] The role of infection in acute exacerbations of chronic obstructive pulmonary disease
    Hillberg, RE
    AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (08): : S427 - S436